开云app官网登录入口网页版-官方正版

#病毒抗体#

31篇内容 | 1322人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2016442, encodeId=1e202016442e4, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=Pediatrics：儿童和青少年自然感染新型冠状病毒抗体的持久性, objectType=article, longId=723455, objectId=3b64e234556a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b64e234556a, replyNumber=0, likeNumber=79, createdTime=2022-04-07, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b64e234556a, moduleTitle=Pediatrics：儿童和青少年自然感染新型冠状病毒抗体的持久性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3b64e234556a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016441, encodeId=04b32016441b2, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=JAMA子刊：通过母乳将新冠病毒抗体传递给宝宝，孕妈妈该接种哪种疫苗？, objectType=article, longId=300849, objectId=c63f30084914, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c63f30084914, replyNumber=0, likeNumber=89, createdTime=2022-05-25, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c63f30084914, moduleTitle=JAMA子刊：通过母乳将新冠病毒抗体传递给宝宝，孕妈妈该接种哪种疫苗？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c63f30084914)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016443, encodeId=c3c82016443bf, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=Nature：感染后产生的新冠病毒抗体，却成了导致重症和死亡的帮凶？, objectType=article, longId=724302, objectId=0ce0e24302f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ce0e24302f8, replyNumber=0, likeNumber=67, createdTime=2022-08-24, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ce0e24302f8, moduleTitle=Nature：感染后产生的新冠病毒抗体，却成了导致重症和死亡的帮凶？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0ce0e24302f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016440, encodeId=6ddb201644009, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=bioRxiv：Omicron为何感染力增强？徐华强团队解开其S蛋白与受体、抗病毒抗体复合物结构, objectType=article, longId=293324, objectId=b2c329332403, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2c329332403, replyNumber=0, likeNumber=69, createdTime=2022-07-11, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2c329332403, moduleTitle=bioRxiv：Omicron为何感染力增强？徐华强团队解开其S蛋白与受体、抗病毒抗体复合物结构, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b2c329332403)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016439, encodeId=f7ff20164394e, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=BMC Infect Dis：母体脊灰病毒抗体对婴儿对脊灰病毒疫苗免疫反应的影响, objectType=article, longId=213456, objectId=37a721345664, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37a721345664, replyNumber=0, likeNumber=80, createdTime=2021-10-26, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37a721345664, moduleTitle=BMC Infect Dis：母体脊灰病毒抗体对婴儿对脊灰病毒疫苗免疫反应的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=37a721345664)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016437, encodeId=0e76201643e8e, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=Lancet：重磅！仅2.7%的武汉人群产生有效新冠病毒抗体, objectType=article, longId=208738, objectId=330b208e38ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=330b208e38ab, replyNumber=0, likeNumber=75, createdTime=2021-04-21, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=330b208e38ab, moduleTitle=Lancet：重磅！仅2.7%的武汉人群产生有效新冠病毒抗体, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=330b208e38ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016438, encodeId=6827201643893, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=2021年3月20日全球新冠肺炎（COVID-19）疫情简报，确诊超1亿2286万，新冠病毒抗体可能维持达9个月，印度疫苗接种提速, objectType=article, longId=208750, objectId=ee8d208e508d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee8d208e508d, replyNumber=0, likeNumber=0, createdTime=2021-07-12, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee8d208e508d, moduleTitle=2021年3月20日全球新冠肺炎（COVID-19）疫情简报，确诊超1亿2286万，新冠病毒抗体可能维持达9个月，印度疫苗接种提速, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ee8d208e508d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016430, encodeId=0d602016430dc, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=君实与礼来制药达成2.55亿美元新冠病毒抗体授权合作！, objectType=article, longId=193477, objectId=8a501934e783, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a501934e783, replyNumber=0, likeNumber=81, createdTime=2020-11-12, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a501934e783, moduleTitle=君实与礼来制药达成2.55亿美元新冠病毒抗体授权合作！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8a501934e783)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016436, encodeId=73c1201643621, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=Science：已有的冠状病毒抗体有助于保护儿童免受新的大流行毒株的侵袭, objectType=article, longId=203069, objectId=9ca020306940, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ca020306940, replyNumber=0, likeNumber=68, createdTime=2021-01-02, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ca020306940, moduleTitle=Science：已有的冠状病毒抗体有助于保护儿童免受新的大流行毒株的侵袭, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9ca020306940)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016431, encodeId=de30201643162, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=罗氏新冠病毒抗体检测技术获美国FDA紧急使用授权, objectType=article, longId=193509, objectId=566119350927, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=566119350927, replyNumber=0, likeNumber=76, createdTime=2020-12-29, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=566119350927, moduleTitle=罗氏新冠病毒抗体检测技术获美国FDA紧急使用授权, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=566119350927)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016426, encodeId=1eb22016426af, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=新冠病毒抗体检测，你知道对疫情防控有多重要吗？, objectType=article, longId=191949, objectId=271e19194959, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=271e19194959, replyNumber=0, likeNumber=70, createdTime=2021-01-28, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=271e19194959, moduleTitle=新冠病毒抗体检测，你知道对疫情防控有多重要吗？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=271e19194959)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016427, encodeId=7fec201642e23, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=三星制药和Vir生物技术公司签署了大规模生产新冠病毒抗体的协议，以治疗COVID-19, objectType=article, longId=192012, objectId=937719201220, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=937719201220, replyNumber=0, likeNumber=73, createdTime=2020-11-30, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=937719201220, moduleTitle=三星制药和Vir生物技术公司签署了大规模生产新冠病毒抗体的协议，以治疗COVID-19, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=937719201220)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016435, encodeId=8e99201643562, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=EClinicalMedicine：老年人产生新冠病毒抗体的能力不输年轻人, objectType=article, longId=203000, objectId=8cda2030007d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cda2030007d, replyNumber=0, likeNumber=76, createdTime=2021-09-12, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cda2030007d, moduleTitle=EClinicalMedicine：老年人产生新冠病毒抗体的能力不输年轻人, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8cda2030007d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016434, encodeId=23672016434dd, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=Nat BME :集成方法可加快发现抗病毒抗体疗法的速度, objectType=article, longId=198846, objectId=505719884680, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=505719884680, replyNumber=0, likeNumber=75, createdTime=2020-12-24, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=505719884680, moduleTitle=Nat BME :集成方法可加快发现抗病毒抗体疗法的速度, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=505719884680)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016423, encodeId=068a201642322, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=MedRxiv：SARS病毒抗体可长期存在, objectType=article, longId=188311, objectId=79ef1883117d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79ef1883117d, replyNumber=0, likeNumber=69, createdTime=2020-10-23, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79ef1883117d, moduleTitle=MedRxiv：SARS病毒抗体可长期存在, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=79ef1883117d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016432, encodeId=ae68201643206, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=浙江新冠病毒抗体检测定价40元，发热门诊患者可医保报销, objectType=article, longId=193730, objectId=e831193e304b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e831193e304b, replyNumber=0, likeNumber=67, createdTime=2020-05-11, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e831193e304b, moduleTitle=浙江新冠病毒抗体检测定价40元，发热门诊患者可医保报销, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e831193e304b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016429, encodeId=696620164298d, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=Lancet infection diseases：重大发现，华中科技大学团队发现新冠肺炎病毒抗体可长期存在，羊水中不能检测到新冠病毒, objectType=article, longId=192997, objectId=cd9019299e1e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd9019299e1e, replyNumber=0, likeNumber=71, createdTime=2020-06-30, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd9019299e1e, moduleTitle=Lancet infection diseases：重大发现，华中科技大学团队发现新冠肺炎病毒抗体可长期存在，羊水中不能检测到新冠病毒, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cd9019299e1e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016433, encodeId=040f2016433a2, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=加拿大卫生部批准首例新冠病毒抗体的血清学测试, objectType=article, longId=194148, objectId=4528194148c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4528194148c3, replyNumber=0, likeNumber=80, createdTime=2020-06-11, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4528194148c3, moduleTitle=加拿大卫生部批准首例新冠病毒抗体的血清学测试, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4528194148c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016425, encodeId=df89201642523, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=bioRxiv：科学家成功分离高效抗新冠病毒抗体, objectType=article, longId=191153, objectId=261619115349, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=261619115349, replyNumber=0, likeNumber=77, createdTime=2021-01-06, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=261619115349, moduleTitle=bioRxiv：科学家成功分离高效抗新冠病毒抗体, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=261619115349)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016422, encodeId=b4c32016422d2, content=<a href='/topic/show?id=d93ee0948f6' target=_blank style='color:#2F92EE;'>#病毒抗体#</a>, objectTitle=MedRxiv：SARS病毒抗体在体内存在可超过12年！, objectType=article, longId=188245, objectId=f71918824585, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f71918824585, replyNumber=0, likeNumber=70, createdTime=2020-02-20, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f71918824585, moduleTitle=MedRxiv：SARS病毒抗体在体内存在可超过12年！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f71918824585)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

病毒抗体

2020-05-29

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

Pediatrics：儿童和青少年自然感染新型冠状病毒抗体的持久性

2022-04-07

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

JAMA子刊：通过母乳将新冠病毒抗体传递给宝宝，孕妈妈该接种哪种疫苗？

2022-05-25

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

Nature：感染后产生的新冠病毒抗体，却成了导致重症和死亡的帮凶？

2022-08-24

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

bioRxiv：Omicron为何感染力增强？徐华强团队解开其S蛋白与受体、抗病毒抗体复合物结构

2022-07-11

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

BMC Infect Dis：母体脊灰病毒抗体对婴儿对脊灰病毒疫苗免疫反应的影响

2021-10-26

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

Lancet：重磅！仅2.7%的武汉人群产生有效新冠病毒抗体

2021-04-21

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

2021年3月20日全球新冠肺炎（COVID-19）疫情简报，确诊超1亿2286万，新冠病毒抗体可能维持达9个月，印度疫苗接种提速

2021-07-12

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

君实与礼来制药达成2.55亿美元新冠病毒抗体授权合作！

2020-11-12

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

Science：已有的冠状病毒抗体有助于保护儿童免受新的大流行毒株的侵袭

2021-01-02

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

罗氏新冠病毒抗体检测技术获美国FDA紧急使用授权

2020-12-29

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

新冠病毒抗体检测，你知道对疫情防控有多重要吗？

2021-01-28

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

三星制药和Vir生物技术公司签署了大规模生产新冠病毒抗体的协议，以治疗COVID-19

2020-11-30

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

EClinicalMedicine：老年人产生新冠病毒抗体的能力不输年轻人

2021-09-12

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

Nat BME :集成方法可加快发现抗病毒抗体疗法的速度

2020-12-24

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

MedRxiv：SARS病毒抗体可长期存在

2020-10-23

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

浙江新冠病毒抗体检测定价40元，发热门诊患者可医保报销

2020-05-11

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

Lancet infection diseases：重大发现，华中科技大学团队发现新冠肺炎病毒抗体可长期存在，羊水中不能检测到新冠病毒

2020-06-30

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

加拿大卫生部批准首例新冠病毒抗体的血清学测试

2020-06-11

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

bioRxiv：科学家成功分离高效抗新冠病毒抗体

2021-01-06

wetgdt (审核中...)

前往app查看评论内容

#病毒抗体#

MedRxiv：SARS病毒抗体在体内存在可超过12年！

2020-02-20

科室
- - 订阅+
  - 更多科室
工具
服务